Champions Oncology, Inc.
CSBR · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $94,337 | $87,143 | $98,338 | $150,570 |
| - Cash | $8,516 | $10,325 | $9,785 | $3,202 |
| + Debt | $5,269 | $5,750 | $6,105 | $6,437 |
| Enterprise Value | $91,090 | $82,568 | $94,658 | $153,805 |
| Revenue | $15,035 | $13,995 | $12,355 | $17,039 |
| % Growth | 7.4% | 13.3% | -27.5% | – |
| Gross Profit | $7,416 | $5,642 | $4,690 | $10,024 |
| % Margin | 49.3% | 40.3% | 38% | 58.8% |
| EBITDA | $612 | -$94 | -$1,570 | $4,916 |
| % Margin | 4.1% | -0.7% | -12.7% | 28.9% |
| Net Income | $299 | -$436 | -$1,834 | $4,495 |
| % Margin | 2% | -3.1% | -14.8% | 26.4% |
| EPS Diluted | 0.019 | -0.032 | -0.13 | 0.31 |
| % Growth | 158.5% | 75.7% | -141.9% | – |
| Operating Cash Flow | -$1,735 | $600 | $6,868 | $490 |
| Capital Expenditures | -$242 | -$46 | -$253 | -$42 |
| Free Cash Flow | -$1,977 | $554 | $6,615 | $448 |